Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00084604
Status:
COMPLETED
Last Update Posted:
2013-06-04
First Post:
2004-06-10
Brief Title:
Irinotecan Cisplatin and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Gastric Cancer |
| Adenocarcinoma of the Gastroesophageal Junction |
| Diffuse Adenocarcinoma of the Stomach |
| Intestinal Adenocarcinoma of the Stomach |
| Mixed Adenocarcinoma of the Stomach |
| Recurrent Gastric Cancer |
| Stage IIIA Gastric Cancer |
| Stage IIIB Gastric Cancer |
| Stage IIIC Gastric Cancer |
Keywords: